Metesind glucuronate structure
|
Common Name | Metesind glucuronate | ||
---|---|---|---|---|
CAS Number | 157182-23-5 | Molecular Weight | 630.666 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C23H24N4O3SC6.H10O7 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Metesind glucuronateMetesind glucuronate (AG 331;AG-265 glucuronate) is a potent thymidylate synthase (TS) inhibitor with IC50/IC90 of 0.7/3.0 uM; inhibits the cofactor binding site of TS, and accumulates in the S phase of the cell cycle in H35 cells at 10 uM. Brain Cancer Discontinued |
Name | Metesind glucuronate |
---|---|
Synonym | More Synonyms |
Description | Metesind glucuronate (AG 331;AG-265 glucuronate) is a potent thymidylate synthase (TS) inhibitor with IC50/IC90 of 0.7/3.0 uM; inhibits the cofactor binding site of TS, and accumulates in the S phase of the cell cycle in H35 cells at 10 uM. Brain Cancer Discontinued |
---|---|
References | References 1. Pressacco J, et al. Cancer Res. 1995 Apr 1;55(7):1505-8. 2. O'Connor BM, et al. Cancer Chemother Pharmacol. 1994;34(3):225-9. 3. Panadero A, et al. Oncol Res. 1995;7(2):73-81. View Related Products by Target Nucleoside Antimetabolite/Analog Brain Cancer |
Molecular Formula | C23H24N4O3SC6.H10O7 |
---|---|
Molecular Weight | 630.666 |
Exact Mass | 630.199585 |
4-((4-(((2-Aminobenz[cd]indol-6-yl)methylamino)methyl)phenyl)sulfonyl)morpholine mono-D-Glucuronate |
Benz[cd]indole-2,6-diamine, N6-methyl-N6-[[4-(4-morpholinylsulfonyl)phenyl]methyl]-, compd. with β-D-glucopyranuronic acid (1:1) |
N6-Methyl-N6-[4-(4-morpholinylsulfonyl)benzyl]benzo[cd]indole-2,6-diamine - β-D-glucopyranuronic acid (1:1) |
4-((a-((2-Aminobenz[cd]indol-6-yl)methylamino)-p-tolyl)sulfonyl)morpholine mono-D-Glucuronate |
Metesind glucuronate |
N6-methyl-N6-[4-(morpholin-4-ylsulfonyl)benzyl]benzo[cd]indole-2,6-diamine - β-D-glucopyranuronic acid (1:1) |